Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'

Detalles Bibliográficos
Autores principales: Badrick, Ellena, Sperrin, Matthew, Renehan, Andrew G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891518/
https://www.ncbi.nlm.nih.gov/pubmed/27219288
http://dx.doi.org/10.1038/bjc.2016.99
_version_ 1782435276739575808
author Badrick, Ellena
Sperrin, Matthew
Renehan, Andrew G
author_facet Badrick, Ellena
Sperrin, Matthew
Renehan, Andrew G
author_sort Badrick, Ellena
collection PubMed
description
format Online
Article
Text
id pubmed-4891518
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48915182016-06-10 Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer' Badrick, Ellena Sperrin, Matthew Renehan, Andrew G Br J Cancer Letter to the Editor Nature Publishing Group 2016-05-24 2016-05-24 /pmc/articles/PMC4891518/ /pubmed/27219288 http://dx.doi.org/10.1038/bjc.2016.99 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Letter to the Editor
Badrick, Ellena
Sperrin, Matthew
Renehan, Andrew G
Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title_full Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title_fullStr Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title_full_unstemmed Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title_short Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
title_sort comment on ‘new-onset type 2 diabetes, elevated hba1c, anti-diabetic medications, and risk of pancreatic cancer'
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891518/
https://www.ncbi.nlm.nih.gov/pubmed/27219288
http://dx.doi.org/10.1038/bjc.2016.99
work_keys_str_mv AT badrickellena commentonnewonsettype2diabeteselevatedhba1cantidiabeticmedicationsandriskofpancreaticcancer
AT sperrinmatthew commentonnewonsettype2diabeteselevatedhba1cantidiabeticmedicationsandriskofpancreaticcancer
AT renehanandrewg commentonnewonsettype2diabeteselevatedhba1cantidiabeticmedicationsandriskofpancreaticcancer

Ejemplares similares